HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less radiation be just as effective for HPV throat cancer?
Disease control OngoingThis study tests whether a much lower dose of radiation (30 Gy) combined with standard chemotherapy works as well as the usual high dose (70 Gy) for people with HPV-positive throat cancer. The goal is to reduce side effects while still controlling the cancer. About 316 participan…
Matched conditions: HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
Could less radiation be enough? new trial aims to reduce treatment burden for HPV throat cancer patients
Disease control OngoingThis study is testing whether a shorter course of lower-dose radiation after robotic surgery is safe for people with HPV-related throat cancer. About 104 participants will receive this de-intensified treatment to see if it controls the cancer while reducing side effects. The goal…
Matched conditions: HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 04, 2026 16:30 UTC